col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


18 Ergebisse       Seite 1

 [1] 
Springer-Verlag: Diabetology International
  Original Artikel Datum Titel Autoren   Max. 6 Autoren
1 [GO] 2025―Feb―03 Impact of a COVID-19 emergency declaration on blood glucose levels in individuals with type 1 diabetes treated with a sensor-augmented pump Tomofumi Takayoshi, Yushi Hirota, Akane Yamamoto, Kai Yoshimura, Seiji Nishikage, Mariko Ueda, Wataru Ogawa
2 [GO] 2024―Jul―27 Role of the receptor for advanced glycation end products in the severity of SARS-CoV-2 infection in diabetic patients Adriana Pedreañez, Jesús A. Mosquera-Sulbaran, Diego Tene
3 [GO] 2024―Mai―30 Case of new-onset fulminant type 1 diabetes mellitus accompanied by autoimmune thyroid disease after SARS-CoV-2 infection Keisuke Murakawa, Hiroaki Aasi, Kanako Sato, Saori Yoshioka, Hiroyuki Sho, Ryoko Inui, Motohiro Kosugi, Yoji Hazama, Tetsuyuki Yasuda
4 [GO] 2024―Apr―08 Influence of the COVID-19 pandemic on the achievement of guideline targets for HbA1c, blood pressure, and LDL cholesterol in people with diabetes in Japan Shingo Kuwajima, Takahito Itoh, Tatsuya Sato, Shoya Ino, Satoru Shibata, Kouhei Ohno, Hiroyuki Hotta, Tomoaki Matsumoto, Hitoshi Ooiwa, Hirofumi Kubo, Takayuki Miki
5 [GO] 2024―Feb―29 Type 1 diabetes mellitus following COVID-19 vaccination: a report of two cases and review of literature Shota Mochizuki, Junnosuke Miura, Kiwako Ucida, Ryo Kubota, Hirona Fujikawa, Satoshi Takagi, Naoshi Yoshida, Sachiko Ootake, Chika Fujimori, Akihito Shinohara, Junji Tanaka, Tetsuya Babazono
6 [GO] 2023―Aug―07 Glucose control in the early phase of hospitalization is associated with severe prognosis in coronavirus disease 2019 (COVID-19) patients with diabetes in Japan Yukiyoshi Okauchi, Ryuki Sakamoto, Tomoko Kaketaka, Eri Yamabayashi, Motohiro Kubori, Shinya Inada, Osamu Morimura, Yasushi Otani, Kinya Abe, Tsutomu Nishida, Hiromi Iwahashi
7 [GO] 2023―Jul―31 Anti-GAD antibody-positive fulminant type 1 diabetes developed following SARS-CoV-2 vaccination Tomohito Izumi, Hironobu Takahashi, Hironori Takahashi
8 [GO] 2023―Jul―01 Impact of prediabetes with a high risk of diabetes stratified by glycated hemoglobin level on the severity of coronavirus disease 2019 during admission Seizaburo Masuda, Tetsuya Yamada, Nozomi Hanzawa
9 [GO] 2022―Dez―23 Diabetic ketoacidosis after the second dose of SARS-CoV-2 mRNA vaccination in a patient with pembrolizumab-induced fulminant type 1 diabetes Kohei Nishino, Kimiko Nakagawa, Eriko Yase, Mariko Terashima, Takashi Murata
10 [GO] 2022―Mai―05 Antibody levels in people with diabetes after one dose of the ChAdOx1 nCoV-19 (AZD1222) vaccine Vimonsri Rangsrisaeneepitak, Thachanun Porntharukchareon, Bothamai Dechates, Supamas Sirisreetreerux, Kriangkrai Tawinprai
11 [GO] 2022―Mrz―08 Seasonal variations and the influence of COVID-19 pandemic on hemoglobin A1c, glycoalbumin, and low-density lipoprotein cholesterol Kohzo Takebayashi, Mototaka Yamauchi, Kenji Hara, Takafumi Tsuchiya, Koshi Hashimoto
12 [GO] 2021―Mai―12 Evaluation of perceived fears of COVID-19 virus infection and its relationship to health-related quality of life among patients with diabetes mellitus in Egypt during pandemic: a developing country single-center study Mohamed Abdelghani, Mohamed G. Hamed, Amira Said, Eman Fouad
13 [GO] 2021―Apr―19 The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study Yukako Hosomi, Chihiro Munekawa, Yoshitaka Hashimoto, Takuro Okamura, Fuyuko Takahashi, Rena Kawano, Hanako Nakajima, Saori Majima, Takafumi Senmaru, Naoko Nakanishi, Emi Ushigome, Masahide Hamaguchi, Masahiro Yamazaki, Michiaki Fukui
14 [GO] 2021―Mrz―23 Diabetes-related acute metabolic emergencies in COVID-19 patients: a systematic review and meta-analysis Vasileios P. Papadopoulos, Marios-Vasileios Koutroulos, Dimitra-Georgia Zikoudi, Stefania-Aspasia Bakola, Peny Avramidou, Ntilara Touzlatzi, Dimitrios K. Filippou
15 [GO] 2021―Mrz―01 Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report Atsushi Satomura, Yoichi Oikawa, Shunpei Nakanishi, Sotaro Takagi, Gen Mizutani, Shinichiro Iida, Hideto Nakayama, Yoshiyuki Haga, Makoto Nagata, Shigefumi Maesaki, Toshihide Mimura, Akira Shimada
16 [GO] 2020―Okt―28 COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report Daniel Valente Batista, Carla Antoniana Ferreira de Almeida Vieira, Thomaz Alexandre Costa, Eduardo Gomes Lima
17 [GO] 2020―Sep―30 Behavioral changes in patients with diabetes during the COVID-19 pandemic Miyako Kishimoto, Takuya Ishikawa, Masato Odawara
18 [GO] 2020―Jun―19 Ethics and practical mitigations for ongoing clinical trials during the COVID-19 pandemic Shota Suzuki, Yukie Ito, Shu Kasama, Takashi Murata, Munehide Matsuhisa, Masato Kasahara
 [1] 

18 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec